Healthcare provider profile · identity verified

Chadi Kaba, M.D.

Internal Medicine · ATTLEBORO, MA · NPI 1811945694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	633	155
Amlodipine Besylate	Amlodipine Besylate	435	109
Losartan Potassium	Losartan Potassium	399	97
Lisinopril	Lisinopril	396	111
Omeprazole	Omeprazole	328	77
Hydrochlorothiazide	Hydrochlorothiazide	281	75
Metoprolol Succinate	Metoprolol Succinate	273	77
Levothyroxine Sodium	Levothyroxine Sodium	270	60
Gabapentin	Gabapentin	247	59
Metformin Hcl	Metformin Hcl	198	54
Albuterol Sulfate Hfa	Albuterol Sulfate	178	46
Trazodone Hcl	Trazodone Hcl	176	48
Rosuvastatin Calcium	Rosuvastatin Calcium	155	50
Sertraline Hcl	Sertraline Hcl	141	35
Alendronate Sodium	Alendronate Sodium	140	37
Simvastatin	Simvastatin	140	37
Tramadol Hcl	Tramadol Hcl	132	39
Eliquis	Apixaban	131	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	22
Tamsulosin Hcl	Tamsulosin Hcl	123	34
Jardiance	Empagliflozin	119	18
Fluticasone Propionate	Fluticasone Propionate	117	46
Furosemide	Furosemide	112	35
Atenolol	Atenolol	101	29
Lorazepam	Lorazepam	101	30
Ozempic	Semaglutide	101	11
Pantoprazole Sodium	Pantoprazole Sodium	100	25
Januvia	Sitagliptin Phosphate	98	15
Fluoxetine Hcl	Fluoxetine Hcl	94	17
Oxycodone Hcl	Oxycodone Hcl	94	22
Alprazolam	Alprazolam	81	20
Allopurinol	Allopurinol	78	18
Celecoxib	Celecoxib	72	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	66	18
Potassium Chloride	Potassium Chloride	61	20
Clonazepam	Clonazepam	60	15
Pravastatin Sodium	Pravastatin Sodium	56	16
Ibuprofen	Ibuprofen	53	15
Aripiprazole	Aripiprazole	49	suppressed
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Lovastatin	Lovastatin	45	13
Memantine Hcl	Memantine Hcl	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	12
Escitalopram Oxalate	Escitalopram Oxalate	43	suppressed
Xarelto	Rivaroxaban	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Terazosin Hcl	Terazosin Hcl	42	12
Mirtazapine	Mirtazapine	41	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Spironolactone	Spironolactone	40	suppressed
Ezetimibe	Ezetimibe	38	11
Irbesartan	Irbesartan	38	11
Warfarin Sodium	Warfarin Sodium	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	18
Prednisone	Prednisone	36	12
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Buspirone Hcl	Buspirone Hcl	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Finasteride	Finasteride	31	suppressed
Glipizide	Glipizide	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Meloxicam	Meloxicam	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Famotidine	Famotidine	26	suppressed
Valsartan	Valsartan	26	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	14
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	suppressed
Estradiol	Estradiol	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Baclofen	Baclofen	19	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Torsemide	Torsemide	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Testosterone	Testosterone	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Diazepam	Diazepam	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Folic Acid	Folic Acid	14	suppressed
Nystatin	Nystatin	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Ec-Naproxen	Naproxen	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Methimazole	Methimazole	12	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Cephalexin	Cephalexin	11	11
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error